U-M Health Neurologists Available To Discuss Alzheimer's Drug FDA Approval
January 09, 2023
January 09, 2023
ANN ARBOR, Michigan, Jan. 9 (TNSres) -- The University of Michigan issued the following news release:
The U.S. Food and Drug Administration has granted accelerated approval for lecanemab, an Alzheimer's disease drug for which studies showed the promising biological effect of removal of the brain's amyloid buildup that occurs in the disease.
University of Michigan Health has an expert available to talk about the accelerated approval and what it could mean for t . . .
The U.S. Food and Drug Administration has granted accelerated approval for lecanemab, an Alzheimer's disease drug for which studies showed the promising biological effect of removal of the brain's amyloid buildup that occurs in the disease.
University of Michigan Health has an expert available to talk about the accelerated approval and what it could mean for t . . .